Pre-Sedation Fluid Replacement and Duodenal Passage Effects on Intraocular Pressure
ENDO-IOP
The Effects of Pre-Sedation Fluid Replacement and Endoscopic Duodenal Passage on Intraocular Pressure: A Prospective Observational Study
1 other identifier
observational
40
1 country
1
Brief Summary
This prospective observational study investigates whether routine pre-sedation isotonic fluid replacement and the passage of the endoscope into the duodenum acutely affect intraocular pressure (IOP) in adult patients undergoing diagnostic upper gastrointestinal endoscopy. A non-contact tonometer is used to measure IOP at four predefined time points: baseline, after pre-sedation fluid replacement, after sedoanalgesia, and immediately following duodenal intubation. Hemodynamic parameters, oxygen saturation, and sedative doses are also recorded. The primary aim is to determine changes in IOP during the procedure, while secondary outcomes include the relationship between hemodynamic fluctuations, sedative requirements, and IOP changes. The findings are expected to provide insights into the safety of endoscopy with respect to ocular physiology, particularly in patients at risk of increased intraocular pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2025
CompletedStudy Start
First participant enrolled
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
September 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2025
CompletedDecember 3, 2025
November 1, 2025
1 month
September 16, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Intraocular Pressure (IOP)
IOP is measured using a calibrated non-contact tonometer at four predefined time points: baseline, after isotonic fluid replacement, after sedoanalgesia, and after endoscopic duodenal passage. Measurements are obtained from the same eye in the same patient position to ensure consistency.
During the procedure (baseline, after fluid replacement, after sedoanalgesia, and immediately after duodenal intubation; total duration ≈ 30 minutes)
Secondary Outcomes (4)
Change in Systolic Blood Pressure (SBP)
During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)
Change in Diastolic Blood Pressure (DBP)
During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)
Change in Mean Arterial Pressure (MAP)
During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)
Change in Heart Rate (HR)
During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)
Study Arms (1)
Upper GI Endoscopy Patients
Adult patients (≥18 years) undergoing diagnostic upper gastrointestinal endoscopy with standard pre-sedation isotonic fluid replacement and sedoanalgesia. Intraocular pressure is measured at four predefined time points: baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation.
Interventions
Participants undergo routine diagnostic upper gastrointestinal endoscopy with standard institutional care. No additional intervention is applied beyond usual clinical practice.
Eligibility Criteria
Adult patients (≥18 years) scheduled for diagnostic upper gastrointestinal endoscopy under sedoanalgesia at Elazig Fethi Sekin City Hospital. Consecutive eligible patients will be approached and enrolled after providing informed consent.
You may qualify if:
- Adults ≥18 years
- Scheduled for diagnostic upper gastrointestinal endoscopy under sedoanalgesia
- ASA physical status I-III
- Voluntarily provides informed consent
You may not qualify if:
- History of glaucoma or ocular hypertension
- Previous ocular surgery or ongoing ophthalmological treatment
- Known contraindications to sedoanalgesia (propofol, midazolam, fentanyl)
- ASA physical status IV or higher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elazığ Fethi Sekin City Hospital
Elâzığ, Merkez, 23200, Turkey (Türkiye)
Related Publications (2)
Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008 May;115(5):763-8. doi: 10.1016/j.ophtha.2008.01.013.
PMID: 18452762BACKGROUNDDumonceau JM, Riphaus A, Aparicio JR, Beilenhoff U, Knape JT, Ortmann M, Paspatis G, Ponsioen CY, Racz I, Schreiber F, Vilmann P, Wehrmann T, Wientjes C, Walder B; NAAP Task Force Members. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2010 Nov;42(11):960-74. doi: 10.1055/s-0030-1255728. Epub 2010 Nov 11.
PMID: 21072716BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Sevim Şenol Karataş, MD
Elazığ Fethi Sekin City Hospital, Department of Anesthesiology and Reanimation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Specialist in Anesthesiology
Study Record Dates
First Submitted
September 16, 2025
First Posted
September 24, 2025
Study Start
September 16, 2025
Primary Completion
October 16, 2025
Study Completion
October 16, 2025
Last Updated
December 3, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the study is a single-center observational project with a limited sample size and no data repository plan. Only aggregated results will be reported in publications.